Immune checkpoint inhibitors: recent progress and potential biomarkers
Conn syndrome Conn syndrome is increasingly diagnosed in older people, especially those with treatment-resistant hypertension
In addition, although overweight and obesity is markedly more common, some individuals with advanced HF like HFrEF are also cachexic (Rossignol et al., 2015) and may therefore not benefit from the weight-reducing effect of GLP-1 RAs
However, a formal work-up and diagnosis were never done
[DOI] [PMC free article] [PubMed] 37.Wang L, Wang W, Kaelber DC, Xu R, Berger NA
Many patients who couldn't afford or access brand-name GLP-1 medications describe Direct Meds USA as a viable pathway to beginning evidence-based weight management therapy